MapLight Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for MapLight Therapeutics stock have an average target of 31, with a low estimate of 28 and a high estimate of 34. The average target predicts an increase of 67.66% from the current stock price of 18.49.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$28	$31	$32	$34
Change	+51.43%	+67.66%	+73.07%	+83.88%

Analyst Ratings

The average analyst rating for MapLight Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25
Strong Buy	2
Buy	2
Hold	0
Sell	0
Strong Sell	0
Total	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Matteis Stifel	Stifel	Strong Buy Initiates $28	Strong Buy	Initiates	$28	+51.43%	Nov 21, 2025
Andrew Tsai Jefferies	Jefferies	Strong Buy Initiates $32	Strong Buy	Initiates	$32	+73.07%	Nov 21, 2025
Marc Goodman Leerink Partners	Leerink Partners	Buy Initiates $30	Buy	Initiates	$30	+62.25%	Nov 21, 2025
Sean Laaman Morgan Stanley	Morgan Stanley	Buy Initiates $34	Buy	Initiates	$34	+83.88%	Nov 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.34

from -105.38

EPS Next Year

-3.74

from -5.34

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
EPS	-53.89	-84.45	-105.38	-5.34	-3.74	-4.05
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	5	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-5.39	-2.74
Avg	-5.34	-3.74
Low	-5.23	-4.21

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.